AmpliSeq for Illumina Immune Response Panel

Targeted RNA expression panel investigating 395 genes involved in tumor-immune system interactions. Read More...
Select Product(s)
What products do I need?
Panel

AmpliSeq™ Immune Response Panel for Illumina®

20019169

Price
 
 

Library Prep

AmpliSeq™ Library PLUS (24 Reactions) for Illumina®

20019101

Price
 
 

AmpliSeq™ Library PLUS (96 Reactions) for Illumina®

20019102

Price
 
 

AmpliSeq™ Library PLUS (384 Reactions) for Illumina®

20019103

Price
 
 

Index Adapters

AmpliSeq™ UD Indexes for Illumina® (24 Indexes, 24 Samples)

20019104

Price
 
 

AmpliSeq™ CD Indexes Set A for Illumina®

20019105

Price
 
 

AmpliSeq™ CD Indexes Set B for Illumina®

20019106

Price
 
 

AmpliSeq™ CD Indexes Set C for Illumina®

20019107

Price
 
 

AmpliSeq™ CD Indexes Set D for Illumina®

20019167

Price
 
 

AmpliSeq™ CD Indexes Set A-D for Illumina® (384 Indexes, 384 Samples)

20031676

Price
 
 
Accessory Products

Ampliseq™ cDNA Synthesis for Illumina®

20022654

Price
 
 

AmpliSeq™ for Illumina® Direct FFPE DNA

20023378

Price
 
 

AmpliSeq™ Library Equalizer for Illumina®

20019171

Price
 
 

Product Highlights

The AmpliSeq for Illumina Immune Response Panel is a targeted resequencing research assay for quantitating expression of cancer biomarkers in 395 genes involved in tumor–immune system interactions. Key features include:

  • Relevant Gene Content
    Targeted expression of 395 cancer biomarkers indicative of immunotherapy response
  • Fast, Streamlined Workflow
    Prepare sequencing-ready libraries in a single day from as little as 1 ng of high quality RNA or 10 ng of formalin-fixed, paraffin-embedded (FFPE) RNA input samples
  • Accurate Data
    Detect expression of genes involved in tumor-immune interactions

The Immune Response Panel is part of an integrated RNA-to-annotated variant solution that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS) next-generation sequencing (NGS) technology, and automated analysis.

This panel detects biomarkers associated with different leukocyte subsets, antigen presentation, checkpoint pathways, and tumor progression. The ready-to-use panel saves you the time and effort of identifying targets, designing primers, and optimizing panels.

Learn More About AmpliSeq for Illumina

Frequently Purchased Together

Specifications

Project Recommendations

Related Products